Neurona Therapeutics
AcquiredNeurona Therapeutics is a biotech company in United States, founded in 2008. It has raised $267.3M across 4 rounds, most recently a $102.0M Series C in April 2025.
NRTX-1001 Inhibitory Neuron Cell Therapy
- Employees
- 51–200
- Founded
- 2008
- Business Model
- B2B
- Website
- neuronatherapeutics.com
- Total Funding
- $267.3M
- Last Round
- $102.0M Series CApr 2025
- Rounds
- 4
- Acquisition Date
- Jun 2026
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.
About
Neurona Therapeutics is a clinical-stage biotherapeutics company in San Francisco developing regenerative neural cell therapies for nervous-system disorders, founded in 2008 by UCSF neuroscientists and stem-cell researchers, with co-founder Cory Nicholas as CEO. Lead candidate NRTX-1001, a single-dose allogeneic inhibitory-interneuron cell therapy, reported positive Phase 1/2 data in drug-resistant mesial temporal lobe epilepsy and is advancing to the pivotal Phase 3 EPIC trial intended to support a BLA, with an $8 million CIRM grant supporting the Phase 1/2 program. The company raised $120 million in February 2024 and an oversubscribed $102 million in April 2025 from investors including Fidelity, The Column Group, Viking Global, and UCB Ventures. In April 2026 UCB agreed to acquire Neurona for $650 million upfront plus up to $500 million in milestones; the deal closed in June 2026.
Summary
It lists 51–200 employees. It has raised $267.3M in total across 4 rounds, most recently a $102.0M Series C round in Apr 2025. Investors include Viking Global, California Institute for Regenerative Medicine (CIRM) and The Column Group.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jun 2026
Sign up to see all 5 events
Funding: Venture Round through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neurona-therapeutics"><img src="https://indexed.vc/api/badge/company/neurona-therapeutics" alt="Neurona Therapeutics on Indexed.vc" width="260" height="76" /></a>